AS Latvijas Juras medicinas centrs (ORSE:LJM1R) YoY EBITDA Growth : 147.34% (As of Mar. 2024)

View and export this data going back to 1998. Start your Free Trial

What is AS Latvijas Juras medicinas centrs YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. AS Latvijas Juras medicinas centrs's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 147.34%.

AS Latvijas Juras medicinas centrs's EBITDA per Share for the three months ended in Mar. 2024 was €0.08.

AS Latvijas Juras medicinas centrs YoY EBITDA Growth Historical Data

The historical data trend for AS Latvijas Juras medicinas centrs's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AS Latvijas Juras medicinas centrs YoY EBITDA Growth Chart

AS Latvijas Juras medicinas centrs Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

1,557.14

55.56

176.47

-11.09

-53.93

AS Latvijas Juras medicinas centrs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															-126.61	45.72	648.53	-77.61	147.34

AS Latvijas Juras medicinas centrs YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

AS Latvijas Juras medicinas centrs's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(0.539	-	1.17)	/	\| 1.17 \|
=	-53.93 %

AS Latvijas Juras medicinas centrs's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(0.08	-	-0.169)	/	\| -0.169 \|
=	147.34 %

AS Latvijas Juras medicinas centrs YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of AS Latvijas Juras medicinas centrs's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

AS Latvijas Juras medicinas centrs (ORSE:LJM1R) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » AS Latvijas Juras medicinas centrs (ORSE:LJM1R) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Patversmes iela 23, Riga, LVA, LV-1005

Website

https://www.ljmc.lv

AS Latvijas Juras medicinas centrs is engaged in the provision of healthcare services. It operates hospitals and diagnostic centers. The company offers diagnostics services, magnetic resonance imaging, radiological diagnostics services, and ambulance services. It is also engaged in General medical practice activities, Special medical practice activities, Residential nursing care activities, Retail sale of medical and orthopedic goods in specialized stores, and Other personal service activities. The majority of the revenue is generated from the Ambulatory Medical Services.

AS Latvijas Juras medicinas centrs (ORSE:LJM1R) Headlines

No Headlines